Novo Nordisk A/S’ (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its ...

Weight loss jabs such as Wegovy and Mounjaro could be handed out “on the high street, or at any out-of-two shopping centre”, ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Weight loss drugs can’t replace the power of group support for lasting weight loss, says local expert A Slimming World ...